First Horizon Corporation’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Hold
6,664
0.04% 229
2026
Q1
$1.02M Hold
6,664
0.04% 225
2025
Q4
$919K Hold
6,664
0.04% 220
2025
Q3
$855K Buy
+6,664
New +$813K 0.04% 217
2021
Q2
$1.23M Hold
13,455
0.11% 130
2021
Q1
$1.15M Sell
13,455
-112
-0.8% -$10.1K 0.11% 135
2020
Q4
$1.28M Buy
13,567
+2
+0% +$175 0.13% 128
2020
Q3
$1.18M Buy
+13,565
New +$1.18M 0.13% 120
2013
Q2
$277K Buy
+4,375
New +$285K 0.08% 199

Other funds holding NVS

First Horizon Corporation's NVS Position: Q2 2026 in Review

First Horizon Corporation held its Novartis (NVS) position steady in Q2 2026 at 6,664 shares worth $1.04M. The position accounts for 0.04% of the portfolio, ranked #229.

First Horizon Corporation first reported a position in NVS in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.28M in Q4 2020. 799 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • First Horizon Corporation held 6,664 shares of Novartis worth $1.04M as of Q2 2026.
  • First Horizon Corporation left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.04% of First Horizon Corporation's portfolio in Q2 2026, its #229 holding.
  • First Horizon Corporation first reported a position in Novartis in Q2 2013 and has held it in 9 quarters since.
  • First Horizon Corporation's Novartis position peaked at $1.28M in Q4 2020.
  • 799 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.